| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Angiogenesis in endometrial carcinoma: Therapies and biomarkers, current options, and future perspectives
|
Berger, Amnon A.
|
|
|
160 |
3 |
p. 844-850
|
artikel
|
| 2 |
A novel diagnostic nomogram based on serological and ultrasound findings for preoperative prediction of malignancy in patients with ovarian masses
|
Guo, Yunyun
|
|
|
160 |
3 |
p. 704-712
|
artikel
|
| 3 |
A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer
|
Duska, L.R.
|
|
|
160 |
3 |
p. 688-695
|
artikel
|
| 4 |
A population-based study of causes of death after endometrial cancer according to major risk factors
|
Lees, Brittany
|
|
|
160 |
3 |
p. 655-659
|
artikel
|
| 5 |
Appropriate triage allows aggressive primary debulking surgery with rates of morbidity and mortality comparable to interval surgery after chemotherapy
|
Narasimhulu, Deepa M.
|
|
|
160 |
3 |
p. 681-687
|
artikel
|
| 6 |
Assessment of malnutrition by unintentional weight loss and its implications on oncologic outcomes in patient with locally advanced cervical cancer receiving primary chemoradiation
|
Jou, Jessica
|
|
|
160 |
3 |
p. 721-728
|
artikel
|
| 7 |
Cervical cancer among Swedish women with drug use disorders: A nationwide epidemiological study
|
Dahlman, Disa
|
|
|
160 |
3 |
p. 742-747
|
artikel
|
| 8 |
Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations
|
Ghezelayagh, Talayeh S.
|
|
|
160 |
3 |
p. 786-792
|
artikel
|
| 9 |
Clinical significance of homologous recombination deficiency score testing in endometrial Cancer
|
Siedel, Jean H.
|
|
|
160 |
3 |
p. 777-785
|
artikel
|
| 10 |
Comparisons of emotional health by diagnosis among women with early stage gynecological cancers
|
Messelt, Audrey
|
|
|
160 |
3 |
p. 805-810
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
160 |
3 |
p. vi
|
artikel
|
| 12 |
Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations
|
Hamilton, Chad A.
|
|
|
160 |
3 |
p. 817-826
|
artikel
|
| 13 |
Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part II
|
Hamilton, Chad A.
|
|
|
160 |
3 |
p. 827-834
|
artikel
|
| 14 |
Evaluation of a nationwide Dutch guideline to detect Lynch syndrome in patients with endometrial cancer
|
Tjalsma, A.S.
|
|
|
160 |
3 |
p. 771-776
|
artikel
|
| 15 |
Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary Study
|
Boerner, Thomas
|
|
|
160 |
3 |
p. 696-703
|
artikel
|
| 16 |
Image-guided tumor ablation in gynecologic oncology: Review of interventional oncology techniques and case examples highlighting a collaborative, multidisciplinary program
|
Moynagh, Michael R.
|
|
|
160 |
3 |
p. 835-843
|
artikel
|
| 17 |
Implications of the obesity epidemic for endometrial cancer risk, mortality, and survivorship
|
Felix, Ashley S.
|
|
|
160 |
3 |
p. 643-645
|
artikel
|
| 18 |
Low-grade endometrial stromal sarcoma: A Turkish uterine sarcoma group study analyzing prognostic factors and disease outcomes
|
Ayhan, Ali
|
|
|
160 |
3 |
p. 674-680
|
artikel
|
| 19 |
Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer
|
Kim, Jina
|
|
|
160 |
3 |
p. 735-741
|
artikel
|
| 20 |
Maintaining surgical care delivery during the COVID-19 pandemic: A comparative cohort study at a tertiary gynecological cancer centre
|
Leung, Elaine
|
|
|
160 |
3 |
p. 649-654
|
artikel
|
| 21 |
Perceived social support in patients with endometrial or ovarian cancer: A secondary analysis from the ROGY care study
|
Scheepers, E.R.M.
|
|
|
160 |
3 |
p. 811-816
|
artikel
|
| 22 |
Phase II trial of vaginal cuff brachytherapy followed by dose-dense chemotherapy in early stage endometrial cancer patients with enriched, high-intermediate risk factors for recurrence
|
Castellano, Tara
|
|
|
160 |
3 |
p. 669-673
|
artikel
|
| 23 |
Reducing unnecessary referrals for colposcopy in hrHPV-positive women within the Dutch cervical cancer screening programme: A modelling study
|
Kaljouw, Sylvia
|
|
|
160 |
3 |
p. 713-720
|
artikel
|
| 24 |
Should the risk for uterine cancer influence decision making for prophylactic hysterectomy in BRCA1/2 mutated patients- a systematic review and meta-analysis
|
Nahshon, Chen
|
|
|
160 |
3 |
p. 755-762
|
artikel
|
| 25 |
Surgical margin status and recurrence pattern in invasive vulvar Paget’s disease: A Japanese Gynecologic Oncology Group study
|
Matsuo, Koji
|
|
|
160 |
3 |
p. 748-754
|
artikel
|
| 26 |
The financial burden of PARP inhibitors on patients, payors, and financial assistance programs: Who bears the cost?
|
Goldsberry, Whitney N.
|
|
|
160 |
3 |
p. 800-804
|
artikel
|
| 27 |
The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women
|
Hagemann, Ian S.
|
|
|
160 |
3 |
p. 660-668
|
artikel
|
| 28 |
The psychosexual effects of risk-reducing bilateral salpingo-oophorectomy in female BRCA1/2 mutation carriers: A systematic review of qualitative studies
|
Hickey, India
|
|
|
160 |
3 |
p. 763-770
|
artikel
|
| 29 |
Total and out-of-pocket costs for PARP inhibitors among insured ovarian cancer patients
|
Liang, Margaret I.
|
|
|
160 |
3 |
p. 793-799
|
artikel
|
| 30 |
Unwittingly biased: A note to gynecologic cancer providers
|
Chase, Dana M.
|
|
|
160 |
3 |
p. 646-648
|
artikel
|
| 31 |
Voiding recovery after radical parametrectomy in cervical cancer patients: An international prospective multicentre trial – SENTIX
|
Zapardiel, Ignacio
|
|
|
160 |
3 |
p. 729-734
|
artikel
|
Tijdschrift beschrijving